Nationwide Fund Advisors Sage Therapeutics, Inc. Transaction History

Nationwide Fund Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 01, 2018	SELL	$60.72 - $167.34 $1.53 Million - $4.22 Million	-25,219 Closed	0 $0
Q3 2017 Oct 23, 2017	SELL	$61.4 - $88.52 $27,445 - $39,568	-447 Reduced 1.74%	25,219 $1.57 Million
Q2 2017 Aug 10, 2017	BUY	N/A	25,666	25,666 $2.04 Million

217

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $465M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Nationwide Fund Advisors, based on Form 13F filings with the SEC.

Stay updated on Nationwide Fund Advisors with notifications on news.